Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
|
SA |
|
United Urban Investment Corp
TSE:8960
|
JP |
|
DCM Holdings Co Ltd
TSE:3050
|
JP |
Wall Street
Price Targets
Price Targets Summary
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
According to Wall Street analysts, the average 1-year price target for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is 43.49 SAR with a low forecast of 39.9 SAR and a high forecast of 46.83 SAR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's stock price target?
Price Target
43.49
SAR
According to Wall Street analysts, the average 1-year price target for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is 43.49 SAR with a low forecast of 39.9 SAR and a high forecast of 46.83 SAR.
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Revenue forecast?
Projected CAGR
19%
For the last 3 years the compound annual growth rate for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's revenue is 15%. The projected CAGR for the next 2 years is 19%.
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Operating Income forecast?
Projected CAGR
33%
For the last 3 years the compound annual growth rate for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's operating income is -7%. The projected CAGR for the next 2 years is 33%.
What is Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's Net Income forecast?
Projected CAGR
25%
For the last 3 years the compound annual growth rate for Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC's net income is -4%. The projected CAGR for the next 2 years is 25%.